Remission is not one condition, and buyers do not price it as one: an insured two years out from a stage III diagnosis with a documented recurrence risk is valued very differently from someone nine years out with clean surveillance scans, even when both describe themselves as being in remission. The distance from treatment, the stage at diagnosis, and what the most recent imaging shows are the three facts that actually decide the number.
There is also a harder truth in the middle of this. The healthier the news from the oncologist, the weaker the market’s interest. Families sometimes hear that as unfair. It is simply what a buyer is pricing, and knowing it up front prevents a great deal of wasted paperwork and disappointment.
Below are two households with the same original diagnosis and very different current facts. Follow the one that resembles yours. Every figure carries the year it applied, and tax treatment should be confirmed with your own CPA, since the difference between the two households below is largely a tax difference.
In This Article
- What an Underwriter Reads When the Chart Says Remission
- Household One: The Iversons, Recurrence and a Short Horizon
- Household Two: The Kaurs, Nine Years Clear
- The Tax Line That Separates the Two Households
- Why the Two Households Get Different Answers
- When Selling Is the Wrong Answer, Stated Directly
- Frequently Asked Questions
What an Underwriter Reads When the Chart Says Remission
Life expectancy providers, firms such as ITM TwentyFirst, Fasano Associates or Longevity Services, build a mortality estimate from the actual records rather than from a summary word. What they look for is specific and you can gather it yourself.
- Stage at diagnosis and the pathology, including grade, receptor status where relevant, and node involvement.
- Date of last treatment, and whether treatment was curative in intent or palliative.
- Surveillance results: the most recent imaging and tumor markers, and how long the clean interval has run.
- Recurrence or metastasis, which changes the assessment more than anything else on this list.
- Comorbidity, because a cancer history alongside heart failure or COPD produces a different estimate than cancer history alone.
The practical consequence: two people can both say five years cancer free and receive very different life expectancy estimates. Order the records once, keep the originals and provide copies. See how life expectancy underwriting works and what fair market value means for a policy.
Household One: The Iversons, Recurrence and a Short Horizon
Ruth Iverson, 73, was treated for stage III colon cancer in 2021 and was told she was in remission. In late 2025 imaging found metastatic disease in the liver, and treatment is now aimed at control rather than cure. Her oncologist has discussed prognosis in terms of months to a small number of years. Her husband Dean, 75, has a pension that continues at 60 percent for a survivor.
They own a $400,000 universal life policy on Ruth costing $11,600 a year, and their savings are $58,000. Out-of-pocket treatment costs, travel to a regional cancer center, and a home health aide three days a week are running well beyond what the pension covers.
What is available to them. First, the policy’s own riders. Many contracts contain an accelerated death benefit or terminal illness rider that pays a portion of the face amount early on a qualifying physician certification, often at little or no additional premium and in weeks rather than months. That is the fastest money in the house and it costs nothing to ask about.
Second, and this is the tax point, a viatical settlement, meaning a sale by an insured who is terminally or chronically ill within the meaning of Internal Revenue Code Section 101(g), can produce proceeds that are excluded from income tax when the statute’s certification requirements are met. That treatment is materially different from an ordinary life settlement. Do not assume it applies; ask the CPA to confirm the certification requirements against Ruth’s documentation. See how the viatical exclusion works.
The caution. Dean’s survivor pension is reduced. Before any sale, the family should price what Dean actually needs after Ruth’s death. If the $400,000 is what fills that gap, selling it to fund care today may solve one year and create fifteen bad ones.
Household Two: The Kaurs, Nine Years Clear
Baldev Kaur, 71, was treated for the same disease in 2017. Surveillance has been clean every year since, and his oncologist released him to annual follow-up. He works part time. His wife Harpreet is 68 and healthy.
They own a $300,000 universal life policy costing $9,400 a year, bought when their children were young, and they are asking whether it is still worth carrying.
The honest answer about market value. A 71-year-old with a nine-year clean interval and no other significant impairment will typically receive a long life expectancy estimate, which means either no offer or a low one. The paperwork, medical records retrieval, and underwriting will take two to three months to produce that answer. Households in this position frequently spend a summer on it and decline the result.
What they should do instead. Ask the carrier four free questions. What is the minimum premium that keeps this contract in force to age 100 at guaranteed assumptions? What reduced paid-up face amount is available with no further premiums? What would reducing the face amount to $150,000 do to the premium? And which riders does this contract already contain?
For most households in the Kaur position, one of those four answers resolves the question at no cost. If the coverage genuinely is not needed any more, our page on outliving the need for coverage walks the alternatives, and a policy with no cash value has its own path described in options for a policy with no cash value.
| The Iversons | The Kaurs | |
|---|---|---|
| Disease status | Metastatic recurrence, treatment for control | Nine years clear, annual follow-up |
| Face amount and premium | $400,000 at $11,600 a year | $300,000 at $9,400 a year |
| Likely market interest | Meaningful, and possibly viatical | Weak; long life expectancy estimate |
| Tax treatment to confirm | Section 101(g) exclusion, if certified | Layered basis, ordinary income, capital gain |
| First free step | Ask about the accelerated death benefit rider | Ask for reduced paid-up and minimum premium |
| Biggest risk | Selling coverage the survivor needs | Spending three months for a low offer |
The Tax Line That Separates the Two Households
This is the single largest financial difference between the Iversons and the Kaurs, and it is worth understanding before either family talks to a buyer.
Ordinary life settlement treatment is layered. Proceeds up to your investment in the contract are generally a return of basis, amounts above basis up to the cash surrender value are generally ordinary income, and the excess above the cash surrender value is generally capital gain. The Tax Cuts and Jobs Act of 2017 changed how basis is computed for policy sales, and the IRS addressed the resulting treatment in Revenue Ruling 2020-05.
Viatical treatment under Internal Revenue Code Section 101(g) can exclude proceeds from gross income where the insured is terminally ill, generally meaning certified by a physician as reasonably expected to result in death within 24 months, or chronically ill within the statute’s definition, and where the buyer meets the licensing requirements the statute imposes. The certification and the buyer’s status both matter.
Two practical instructions. Ask your CPA which treatment applies to your facts before you sign anything, because the after-tax difference can exceed the difference between two competing offers. And ask what a lump sum does to anything means-tested in the household, including Medicaid, Medicare Savings Programs and SNAP. A State Health Insurance Assistance Program counselor can review the Medicare side for free.
Why the Two Households Get Different Answers
Three facts drive the divergence, and they are the same three facts every household in this situation should write down.
Disease status, not diagnosis history. Recurrence and metastasis move the estimate; a long clean interval moves it back. The word remission carries almost no information by itself.
Who needs the death benefit. A reduced survivor pension makes the death benefit load-bearing. A household where both spouses have independent income and grown children may genuinely no longer need it.
The premium relative to the household’s income. $11,600 a year against $58,000 of savings is a crisis. $9,400 against a comfortable retirement is a preference.
Compare with a recent cancer diagnosis, where treatment decisions and policy decisions are happening at the same time, and with how age alone affects policy value past 75.
When Selling Is the Wrong Answer, Stated Directly
When the insured is genuinely well. A long clean interval usually means a long life expectancy estimate, weak offers, and months of records gathering for a number you will refuse. If the coverage is affordable, keep it. If it is not, reduce it.
When the face amount is small. Below roughly $100,000 the fixed costs of a transaction consume too much, and the net often lands near the cash surrender value.
When a surviving spouse depends on the benefit, which is the Iverson question and the one families most often answer too fast.
When the policy is the funeral plan, particularly a final expense policy assigned to a funeral home under a pre-need contract, which typically sits inside the burial exclusion benefit programs recognize.
When a rider already in the contract would do the job. An accelerated death benefit costs far less than selling the whole policy and pays much faster.
Where a sale genuinely deserves pricing: a large permanent policy, a documented impairment that shortens the life expectancy estimate, a premium that has become unaffordable, no dependent survivor, and a real risk that the alternative is a lapse returning nothing. Compare any offer against the cash surrender value, against reduced paid-up, and against the after-tax result your CPA calculates. See what guaranteed issue policies are worth if the contract in question is a small final expense policy.
Pine Lake Legacy does not purchase policies and is not licensed in every state. A free policy review is education about your contract, and it is not medical or tax advice; those belong with your oncologist and your CPA.
Frequently Asked Questions
Does being in remission make my policy worth more or less?
It depends on which remission. A long clean interval with good surveillance generally lengthens the life expectancy estimate a buyer prices against, which lowers offers. A recurrence or metastatic disease shortens it and raises interest. The records decide it, so gather the pathology, the treatment dates and the most recent imaging before asking anyone for a valuation.
What is the difference between a viatical and a life settlement here?
Mostly life expectancy and tax treatment. Viatical treatment under Internal Revenue Code Section 101(g) can exclude proceeds from income tax where the insured is certified terminally or chronically ill within the statute’s terms and the buyer meets its requirements. Ordinary life settlement proceeds are taxed in layers. Ask your CPA which applies to your documentation before signing anything.
What records will a buyer ask for?
Generally two to five years of oncology and primary care records: the pathology report and stage at diagnosis, the treatment summary with dates, surveillance imaging and tumor markers, and the current medication list. Order them once through the treating practices, expect two to four weeks per provider, and keep the originals so you can supply copies to multiple parties.
Should we use an accelerated death benefit rider instead of selling?
Check it first, because it is often already in the contract at no additional premium and pays in weeks rather than months. It reduces the eventual death benefit by the amount advanced, plus any charge, so ask the carrier for the exact terms and the effect on the remaining benefit in writing. For a household facing immediate costs it is usually the fastest option.
My spouse’s pension drops when I die. Does that change the analysis?
Substantially. A reduced survivor pension makes the death benefit load-bearing, and selling it to fund current costs can solve one year at the expense of many. Price what the survivor will actually need each year, then decide whether the policy is the thing that fills that gap. This calculation belongs with a fee-only adviser rather than with a buyer.
How long does the process take if we go forward?
Typically 60 to 120 days from application to funding, with most of the time spent on records retrieval and life expectancy underwriting. Keep paying premiums throughout, since a lapse ends the transaction and reinstatement requires evidence of insurability plus back premiums with interest. Ask the carrier for the minimum premium that holds the contract in force meanwhile.
Find out what your policy is worth — free, confidential, no obligation.
A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.
Related Reading
- What Is Policy Fair Market Value
- Recent Cancer Diagnosis Policy
- Policy With No Cash Value Options
- Guaranteed Issue Policy Value
- Age 75 Plus Policy Value
- What Is Life Expectancy Underwriting
- Viatical Tax Exclusion Rules
- Outlived Need For Coverage
Pine Lake Legacy does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.